294 related articles for article (PubMed ID: 26295035)
1. An Overview of Potential Targets for Treating Amyotrophic Lateral Sclerosis and Huntington's Disease.
de Paula CZ; Gonçalves BD; Vieira LB
Biomed Res Int; 2015; 2015():198612. PubMed ID: 26295035
[TBL] [Abstract][Full Text] [Related]
2. Role of connexins in neurodegenerative diseases (Review).
Xing J; Xu C
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of neuronal death in Huntington's disease. Second part: therapeutic challenges].
Bantubungi K; Blum D
Rev Med Brux; 2007; 28(6):487-94. PubMed ID: 18265808
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic advances in neurodegenerative disorders.
Aguilera AJ
Clin Lab Med; 1995 Dec; 15(4):915-26. PubMed ID: 8838230
[TBL] [Abstract][Full Text] [Related]
5. Transgenic animal models of neurodegeneration based on human genetic studies.
Harvey BK; Richie CT; Hoffer BJ; Airavaara M
J Neural Transm (Vienna); 2011 Jan; 118(1):27-45. PubMed ID: 20931247
[TBL] [Abstract][Full Text] [Related]
6. Stem cells as promising therapeutic options for neurological disorders.
Yoo J; Kim HS; Hwang DY
J Cell Biochem; 2013 Apr; 114(4):743-53. PubMed ID: 23097262
[TBL] [Abstract][Full Text] [Related]
7. AMPK in Neurodegenerative Diseases.
Domise M; Vingtdeux V
Exp Suppl; 2016; 107():153-177. PubMed ID: 27812980
[TBL] [Abstract][Full Text] [Related]
8. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.
Iguchi Y; Katsuno M; Niwa J; Takagi S; Ishigaki S; Ikenaka K; Kawai K; Watanabe H; Yamanaka K; Takahashi R; Misawa H; Sasaki S; Tanaka F; Sobue G
Brain; 2013 May; 136(Pt 5):1371-82. PubMed ID: 23449777
[TBL] [Abstract][Full Text] [Related]
9. Effects of exercise on sleep in neurodegenerative disease.
Memon AA; Coleman JJ; Amara AW
Neurobiol Dis; 2020 Jul; 140():104859. PubMed ID: 32243913
[TBL] [Abstract][Full Text] [Related]
10. Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity.
Dentel C; Palamiuc L; Henriques A; Lannes B; Spreux-Varoquaux O; Gutknecht L; René F; Echaniz-Laguna A; Gonzalez de Aguilar JL; Lesch KP; Meininger V; Loeffler JP; Dupuis L
Brain; 2013 Feb; 136(Pt 2):483-93. PubMed ID: 23114367
[TBL] [Abstract][Full Text] [Related]
11. Aerobic glycolysis in amyotrophic lateral sclerosis and Huntington's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Rev Neurosci; 2018 Jul; 29(5):547-555. PubMed ID: 29303786
[TBL] [Abstract][Full Text] [Related]
12. Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis.
Carlesi C; Pasquali L; Piazza S; Lo Gerfo A; Caldarazzo Ienco E; Alessi R; Fornai F; Siciliano G
Arch Ital Biol; 2011 Mar; 149(1):151-67. PubMed ID: 21412722
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria and neurodegeneration.
Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
[TBL] [Abstract][Full Text] [Related]
14. Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington's disease.
Nana AL; Kim EH; Thu DC; Oorschot DE; Tippett LJ; Hogg VM; Synek BJ; Roxburgh R; Waldvogel HJ; Faull RL
J Huntingtons Dis; 2014; 3(1):45-64. PubMed ID: 25062764
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.
Rossi S; Bernardi G; Centonze D
Exp Neurol; 2010 Jul; 224(1):92-102. PubMed ID: 20353778
[TBL] [Abstract][Full Text] [Related]
16. [Morphometric investigation on the neostriatum and spinal cord in extrapyramidal degenerative diseases and amyotrophic lateral sclerosis].
Oyanagi K; Ikuta F
No To Shinkei; 1988 Jan; 40(1):47-54. PubMed ID: 2965893
[No Abstract] [Full Text] [Related]
17. Aging and neurodegeneration. Molecular mechanisms of neuronal loss in Huntington's disease.
Lee ST; Kim M
Mech Ageing Dev; 2006 May; 127(5):432-5. PubMed ID: 16527334
[TBL] [Abstract][Full Text] [Related]
18. The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review.
Cecerska-Heryć E; Pękała M; Serwin N; Gliźniewicz M; Grygorcewicz B; Michalczyk A; Heryć R; Budkowska M; Dołęgowska B
Cell Mol Neurobiol; 2023 Aug; 43(6):2643-2673. PubMed ID: 37027074
[TBL] [Abstract][Full Text] [Related]
19. miRNAs as biomarkers of neurodegenerative disorders.
Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
[TBL] [Abstract][Full Text] [Related]
20. Huntington's disease: from molecular pathogenesis to clinical treatment.
Ross CA; Tabrizi SJ
Lancet Neurol; 2011 Jan; 10(1):83-98. PubMed ID: 21163446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
